| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |